Study Of Palbociclib (PD-0332991) In Renal Impairment

NCT02085538 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
31
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer